Yiwen Kuang

Yiwen Kuang

Auto-generated profile, based on publicly available information

Yiwen Kuang

Department of Oral and Maxillofacial Surgery, Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2025 in Materials Today Bio
Verified
Journal Article
Open access
YKYiwen Kuang
Yiwen Kuang
BHBingqiang Hua
Bingqiang Hua
XYXiaoping Ye
Xiaoping Ye
YZYujin Zhao
Yujin Zhao
MYMeng Yu
Meng Yu
XLXianwen Liu
Xianwen Liu
Temporomandibular joint osteoarthritis (TMJOA) is a degenerative disease characterized by variable degrees of inflammatory cartilage degeneration and subchondral bone erosion. Current clinical treatments mainly focus on symptomatic relief, such as pain management, and no disease-modifying osteoarthritis (OA) drugs (DMOADs) have been approved for widespread clinical use by regulatory bodies. Although fibroblast growth factor (FGF18) has shown great potential to be DMOADs in clinical trials for OA treatment by stimulating cartilage regeneration, its efficacy of inducing anabolic responses in articular cartilage is significantly limited by inflammatory conditions. In this study, we delivered FGF18 using an innovative hydrogel that underwent responsive degradation in the reactive oxygen species (ROS)-enriched TMJOA sites, continuously delivering the cartilage-repairing FGF18 and consuming ROS, further counteracting the limitation of inflammatory factors on cartilage repair ability of FGF18, thereby hindering the progression of TMJOA. This is the first attempt to hinder TMJOA progression with FGF18, and has demonstrated the dual function of hydrogel in reducing inflammation levels and promoting cartilage repair in TMJOA environment. This discovery addresses the limitations of short retention time of FGF18 in clinical applications, and also provides a new strategy for improving articular cartilage repair by overcoming the inflammatory environment.

11 October 2023 in International Immunopharmacology
Verified
Journal Article
Closed access
BHBingqiang Hua
Bingqiang Hua
JQJin Qiu
Jin Qiu
XYXiaoping Ye
Xiaoping Ye
YKYiwen Kuang
Yiwen Kuang
XLXianwen Liu
Xianwen Liu